3 ms·
I personally got CAR T-cell therapy (Yescarta) for Primary Mediastinal Large B-Cell Lymphoma: https://www.yescarta.com/ https://www.yescarta.com/ https://en.w
by msla 4y ago
I personally got CAR T-cell therapy (Yescarta) for Primary Mediastinal Large B-Cell Lymphoma:
https://www.yescarta.com/ https://www.yescarta.com/
https://en.wikipedia.org/wiki/Axicabtagene_ciloleucel https://en.wikipedia.org/wiki/Axicabtagene_ciloleucel
> On 1 April 2022, the FDA approved axicabtagene ciloleucel for adults with large B-cell lymphoma (LBCL) that is refractory to first-line chemoimmunotherapy or relapses within twelve months of first-line chemoimmunotherapy.
I was in a clinical trial, though, but that was to determine the effectiveness of Anakinra in preventing serious side-effects; in my case, I only got a few mild fevers, which is the biochemical equivalent of winning the lottery, in a lottery where losers end up comatose and intubated.
https://en.wikipedia.org/wiki/Anakinra https://en.wikipedia.org/wiki/Anakinra
- sergiotapia 4y agoI am very happy for your outcome, can't imagine the stress and fear you felt. So glad you had success, let's hope this becomes commonplace and people are saved from such a wretched fate.
- msla 4y agoI'm also very happy, especially since I was in complete remission as per a PET/CT scan a month after infusion after my cancer had survived two previous lines of chemotherapy (DA-EPOCH-R and R-GemOx) and had even shrunk but became more metabolically active after the second line. I'm still in complete remission, with further destruction of the tumor, six months after infusion, and there's some evidence the CAR T-cells can persist a decade after infusion: https://www.nature.com/articles/s41586-021-04390-6 https://www.nature.com/articles/s41586-021-04390-6
- worthless-trash 4y agoThis story made my day.
- aledalgrande 4y agoWe need more stories like this.